ePRaSE | Electronic Prescribing and Safety Evaluation

Updates

Latest News & Announcements

16 September 2026 ePRaSE Goes Live

ePRaSE 2026 Is Now Live

The latest version of ePRaSE (Electronic Prescribing Risk and Safety Evaluation) is now available. ePRaSE helps NHS organisations assess, benchmark, and improve the safety and optimisation of their ePrescribing and EPR systems.

Instant feedback on medicines safety risks
National benchmarking and reporting
Adult and Paediatric assessments
Enhanced reporting, archive, and user experience

Know your risk. Improve safety. Drive optimisation.

8 June 2026 HSSIB Recognition

HSSIB Recognises ePRaSE as Key Tool

The latest report from the Health Services Safety Investigations Body (HSSIB) examines the safety of electronic prescribing and medicines administration (ePMA) systems used across NHS acute hospitals and highlights the importance of robust mechanisms for identifying, assessing, and learning from digital medication safety risks.

Within the report, ePRaSE is cited as an important tool that NHS organisations can use to assess whether their ePMA systems are functioning as intended and supporting safe prescribing in practice.

Read the full press release →